chr2-38071052-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000104.4(CYP1B1):c.1302G>A(p.Trp434*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000104.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- CYP1B1-related glaucoma with or without anterior segment dysgenesisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
- glaucoma 3AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
- anterior segment dysgenesis 6Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- congenital glaucomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Peters anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000104.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP1B1 | NM_000104.4 | MANE Select | c.1302G>A | p.Trp434* | stop_gained | Exon 3 of 3 | NP_000095.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP1B1 | ENST00000610745.5 | TSL:1 MANE Select | c.1302G>A | p.Trp434* | stop_gained | Exon 3 of 3 | ENSP00000478561.1 | ||
| CYP1B1 | ENST00000490576.2 | TSL:4 | c.1302G>A | p.Trp434* | stop_gained | Exon 3 of 3 | ENSP00000478839.2 | ||
| CYP1B1 | ENST00000614273.1 | TSL:5 | c.1302G>A | p.Trp434* | stop_gained | Exon 3 of 3 | ENSP00000483678.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461688Hom.: 0 Cov.: 50 AF XY: 0.00 AC XY: 0AN XY: 727124 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Congenital glaucoma Pathogenic:1
A different truncation downstream of this variant (p.Asp449Metfs*8) has been determined to be pathogenic (PMID: 9497261, 27820421, 14635112, 12036985). This suggests that deletion of this region of the CYP1B1 protein is causative of disease. This variant has been reported in an individual affected with primary congenital glaucoma (PMID: 16735994). This sequence change results in a premature translational stop signal in the last exon of the CYP1B1 mRNA at codon 434 (p.Trp434*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 110 amino acids (~20%) of the CYP1B1 protein. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at